Treace Medical Concepts, Inc. (TMCI) Stock Overview
Explore Treace Medical Concepts, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Treace Medical Concepts, Inc. (TMCI)
Key Financials
Key Financials
Market Cap
292.6M
P/E Ratio
-5.16
EPS (TTM)
$-0.94
ROE
-0.74%
TMCI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Treace Medical Concepts, Inc. (NASDAQ: TMCI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Treace Medical Concepts, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TMCI on the NASDAQ shows an RSI of 52.68, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Treace Medical Concepts, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.16 and a market capitalization of 292.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TMCI on the NASDAQ.